A Lafayette, Indiana, physician, Martin J. Maasen, 82, has been federally indicted in connection with an extensive drug trafficking investigation. The U.S. Attorney’s Office for the Western District of Pennsylvania revealed that Maasen is among 12 individuals named in two separate indictments linked to a drug conspiracy allegedly active from early 2019 to mid-2024.
These charges involve the unlawful distribution of controlled substances, including oxycodone and amphetamines.
Maasen faces preliminary charges related to the unlawful distribution of Adderall, with potential penalties of up to 20 years in prison and a $1 million fine. The indictments include 22 counts detailing the alleged drug distribution network, which reportedly operated across western Pennsylvania and beyond.
Adderall, an amphetamine, is known to elevate dopamine and norepinephrine levels in the brain, which help regulate attention and impulse control. While effective for ADHD when prescribed appropriately, Adderall carries a high potential for misuse, especially when used without medical supervision.
Studies have shown that misuse of amphetamines can lead to significant cognitive, cardiovascular, and psychological risks, including dependency and increased tolerance (see the American Journal of Psychiatry for findings on amphetamine-related substance use disorders)one, an opioid analgesic prescribed for severe pain, is also associated with high rates of misuse and dependency.
Recent data show that opioid-related deaths continue to surge, partly due to overprescription and illicit distribution. The Centers for Disease Control and Prevention (CDC) reported over 100,000 drug overdose deaths in the U.S. in 2022 alone, underscoring the need for stricter regulations and comprehensive interventions.
DEA Philadelphia Field Division Special Agent Thomas Hodnett emphasized the seriousness of the allegations, stating that Maasen is accused of illegally distributing powerful drugs, including oxycodone, contributing to the opioid crisis.
Hodnett noted that healthcare providers have a legal duty to prescribe medications strictly for legitimate medical purposes and that violations undermine public trust and harm communities affected by addiction.
Cited from the Western District of Pennsylvania, U.S. Attorney’s Office news release.
Why Choose Sunrise Recovery?
Sunrise Recovery’s approach focuses on both immediate treatment and sustained support through programs tailored to each patient’s needs. The facility offers a continuum of care that includes inpatient, outpatient, and alumni programs, creating pathways for long-term recovery that recognize the complexity of substance use disorders.
The inclusion of Medication-Assisted Treatment (MAT) ensures that patients receive medically supported options to address both the psychological and physical aspects of dependency. With a commitment to ethical practice and compassionate patient care, Sunrise Recovery is equipped to support individuals as they navigate the challenges of recovery.
Recap
The indictment of Dr. Maasen underscores the pressing issue of controlled substance misuse within healthcare and the need for stringent regulatory oversight. Misuse of medications like Adderall and oxycodone can lead to severe personal and public health consequences.
Medical care, especially supervised treatment programs such as Medical Detox, plays a central role in addressing addiction and supporting individuals toward healthier lives. Sunrise Recovery remains dedicated to providing safe, effective treatment options that are in line with both medical and ethical standards.
Next Steps
For individuals struggling with substance use or those affected by the opioid crisis, seeking medically supervised treatment is a critical step toward recovery.
The Sunrise Recovery team is available to discuss tailored addiction rehab treatment plans that meet each person’s unique needs, offering hope and guidance for those ready to begin the journey to recovery. Send us a message to seek help for you or your loved ones today!
